NDA 5657, held by Bristol Myers Squibb. Tubocurarine Chloride.
As of Nov 13, 2026, NDA 5657 (Tubocurarine Chloride), held by Bristol Myers Squibb, was first approved by FDA on Feb 20, 1945, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 20, 1945 | Original applicationNew molecular entity · Priority review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tubocurarine Chloride3MG/ML · injectable;injection | Tubocurarine Chloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 6, 1992 | Supplement 10Manufacturing · Priority review | Approved | None posted |
| Jun 10, 1987 | Supplement 9Labeling · Priority review | Approved | None posted |
| Nov 14, 1986 | Supplement 8Manufacturing · Priority review | Approved | None posted |
| Aug 19, 1985 | Supplement 6Labeling · Priority review | Approved | None posted |
| Jul 22, 1985 | Supplement 7Manufacturing · Priority review | Approved | None posted |
| Jul 28, 1980 | Supplement 5Manufacturing · Priority review | Approved | None posted |
| Apr 29, 1980 | Supplement 4Labeling · Priority review | Approved | None posted |
| Feb 16, 1977 | Supplement 3Labeling · Priority review | Approved | None posted |
| Dec 16, 1976 | Supplement 2Labeling · Priority review | Approved | None posted |
| Nov 28, 1972 | Supplement 1Labeling · Priority review | Approved | None posted |
| Feb 20, 1945 | Original applicationNew molecular entity · Priority review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
